XSF

2-[6-(1-acetylpiperidin-4-yl)-4-oxoquinazolin-3(4H)-yl]-N-{[4-chloro-3-(trifluoromethoxy)phenyl]methyl}-N-methylacetamide

Created:	2023-06-08
Last modified:	2024-12-18

Find Related PDB Entry
1 entries where XSF is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	64
Chiral Atom Count	0
Bond Count	67
Aromatic Bond Count	12

2D diagram of XSF

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-[6-(1-acetylpiperidin-4-yl)-4-oxoquinazolin-3(4H)-yl]-N-{[4-chloro-3-(trifluoromethoxy)phenyl]methyl}-N-methylacetamide
Systematic Name (OpenEye OEToolkits)	~{N}-[[4-chloranyl-3-(trifluoromethyloxy)phenyl]methyl]-2-[6-(1-ethanoylpiperidin-4-yl)-4-oxidanylidene-quinazolin-3-yl]-~{N}-methyl-ethanamide
Formula	C₂₆ H₂₆ Cl F₃ N₄ O₄
Molecular Weight	550.957
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(C)N1CCC(CC1)c1ccc2N=CN(CC(=O)N(C)Cc3ccc(Cl)c(OC(F)(F)F)c3)C(=O)c2c1
SMILES	CACTVS	3.385	CN(Cc1ccc(Cl)c(OC(F)(F)F)c1)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(C)=O
SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCC(CC1)c2ccc3c(c2)C(=O)N(C=N3)CC(=O)N(C)Cc4ccc(c(c4)OC(F)(F)F)Cl
Canonical SMILES	CACTVS	3.385	CN(Cc1ccc(Cl)c(OC(F)(F)F)c1)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(C)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCC(CC1)c2ccc3c(c2)C(=O)N(C=N3)CC(=O)N(C)Cc4ccc(c(c4)OC(F)(F)F)Cl
InChI	InChI	1.06	InChI=1S/C26H26ClF3N4O4/c1-16(35)33-9-7-18(8-10-33)19-4-6-22-20(12-19)25(37)34(15-31-22)14-24(36)32(2)13-17-3-5-21(27)23(11-17)38-26(28,29)30/h3-6,11-12,15,18H,7-10,13-14H2,1-2H3
InChIKey	InChI	1.06	SEYPWJAXDVEKRI-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	122603607

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.